These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9586237)

  • 1. Innovative strategies for the oral delivery of drugs and peptides.
    Fasano A
    Trends Biotechnol; 1998 Apr; 16(4):152-7. PubMed ID: 9586237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Zonula occludens toxin: an innovative method of oral drugs delivery].
    Di Pierro M; Fasano A
    Minerva Pediatr; 2001 Feb; 53(1):15-22. PubMed ID: 11309538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of intestinal permeability: an innovative method of oral drug delivery for the treatment of inherited and acquired human diseases.
    Fasano A
    Mol Genet Metab; 1998 May; 64(1):12-8. PubMed ID: 9682213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel approaches for oral delivery of macromolecules.
    Fasano A
    J Pharm Sci; 1998 Nov; 87(11):1351-6. PubMed ID: 9811489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein drug oral delivery: the recent progress.
    Lee HJ
    Arch Pharm Res; 2002 Oct; 25(5):572-84. PubMed ID: 12433186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Methodologies for regulation of intestinal absorption of biologically active peptides].
    Fujita T; Muranishi S
    Nihon Rinsho; 1998 Mar; 56(3):589-94. PubMed ID: 9549341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral biodrug delivery using cell-penetrating peptide.
    Khafagy el-S; Morishita M
    Adv Drug Deliv Rev; 2012 May; 64(6):531-9. PubMed ID: 22245080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Delivery system design for improvement of intestinal absorption of peptide drugs].
    Muranishi S
    Yakugaku Zasshi; 1997 Jul; 117(7):394-414. PubMed ID: 9261212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral delivery of peptide drugs: barriers and developments.
    Hamman JH; Enslin GM; Kotzé AF
    BioDrugs; 2005; 19(3):165-77. PubMed ID: 15984901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules.
    Choonara BF; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
    Biotechnol Adv; 2014 Nov; 32(7):1269-1282. PubMed ID: 25099657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Improvement of transmucosal absorption of biologically active peptide drugs].
    Yamamoto A
    Yakugaku Zasshi; 2001 Dec; 121(12):929-48. PubMed ID: 11766407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal permeation enhancers for oral peptide delivery.
    Maher S; Mrsny RJ; Brayden DJ
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):277-319. PubMed ID: 27320643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches to improve intestinal and transmucosal absorption of peptide and protein drugs.
    Yamamoto A; Ukai H; Morishita M; Katsumi H
    Pharmacol Ther; 2020 Jul; 211():107537. PubMed ID: 32201316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Improvement of intestinal absorption of peptide and protein drugs by chemical modification with fatty acids].
    Yamamoto A
    Nihon Rinsho; 1998 Mar; 56(3):601-7. PubMed ID: 9549343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmembrane transport of peptide type compounds: prospects for oral delivery.
    Lipka E; Crison J; Amidon GL
    J Control Release; 1996 May; 39(2-3):121-9. PubMed ID: 11539926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches for enhancing oral bioavailability of peptides and proteins.
    Renukuntla J; Vadlapudi AD; Patel A; Boddu SH; Mitra AK
    Int J Pharm; 2013 Apr; 447(1-2):75-93. PubMed ID: 23428883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: in vitro permeability and in vivo oral absorption of salmon calcitonin (sCT).
    Sinko PJ; Lee YH; Makhey V; Leesman GD; Sutyak JP; Yu H; Perry B; Smith CL; Hu P; Wagner EJ; Falzone LM; McWhorter LT; Gilligan JP; Stern W
    Pharm Res; 1999 Apr; 16(4):527-33. PubMed ID: 10227707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials.
    Aguirre TA; Teijeiro-Osorio D; Rosa M; Coulter IS; Alonso MJ; Brayden DJ
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):223-241. PubMed ID: 26921819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using peptides to increase transport across the intestinal barrier.
    Sánchez-Navarro M; Garcia J; Giralt E; Teixidó M
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):355-366. PubMed ID: 27155131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral delivery of peptide therapeutics in infants: Challenges and opportunities.
    Gleeson JP; Fein KC; Whitehead KA
    Adv Drug Deliv Rev; 2021 Jun; 173():112-124. PubMed ID: 33774115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.